Trial Profile
A Phase III Clinical Trial the Immunogenicity and Safety Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Hib-meningococcal vaccine groups A and C conjugate (Primary) ; Meningococcal vaccine groups A and C conjugate
- Indications Haemophilus infections; Meningococcal group A infections; Meningococcal group C infections
- Focus Pharmacodynamics
- 18 Apr 2012 Actual patient number is 2394 according to ClinicalTrials.gov.
- 18 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.